Sumiro Isoda

Title: The Innovative Contributions of Sumiro Isoda

Introduction

Sumiro Isoda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-allergic properties. With a total of 3 patents to his name, Isoda's work has the potential to impact the treatment of various allergic diseases.

Latest Patents

Isoda's latest patents include novel tricyclic triazolopyrimidine derivatives. These compounds, represented by formula (I), are disclosed along with their physiologically acceptable salts. They exhibit excellent anti-allergic activity and are useful for the treatment and prophylaxis of allergic diseases. Another notable patent involves thiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidine compounds, which also demonstrate significant anti-allergic activity when administered orally. These compounds are beneficial for treating conditions such as bronchial asthma, allergic gastrointestinal disorders, allergic rhinitis, hay fever, and urticaria.

Career Highlights

Sumiro Isoda is currently associated with Daiichi Seiyaku Co., Ltd., a leading pharmaceutical company in Japan. His work at the company focuses on innovative drug development aimed at addressing allergic conditions. Isoda's expertise in the field has positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Isoda collaborates with several talented individuals in his field, including Tamotsu Miwa and Shunzo Aibara. These collaborations enhance the research and development efforts at Daiichi Seiyaku Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Sumiro Isoda's contributions to the field of pharmaceuticals, particularly in developing anti-allergic compounds, highlight his role as an influential inventor. His patents reflect a commitment to improving the quality of life for individuals suffering from allergic diseases.